Foundation Board and Staff

Dr Yasmin Harvey is a haematologist at Sullivan Nicolaides Pathology, Brisbane. She supports the important role of research opportunities for pathology trainees and fellows to gain further education and collaboration to improve patient care and clinical outcomes. A graduate of The University of Queensland, with a BSc (Biomedical Science) in 1999 and MBBS (Hons) in 2004, Dr Harvey undertook specialist haematology training at the Princess Alexandra Hospital, The Royal Brisbane Women's and Children's Hospital, and Sullivan Nicolaides Pathology. She was admitted to Fellowship in 2015. She received the RCPA Mike & Carole Ralston Travelling Fellowship Award and completed a research fellowship at the Centre for Lymphoid Cancer, British Columbia Cancer Agency, Canada. Her research interests include application of translational genomic technologies including gene expression-based biomarkers in patients with Hodgkin lymphoma.

Dr Harvey is involved in all aspects of diagnostic haematology and enjoys working closely with her colleagues in clinical practice. She is an RCPA supervisor to advanced haematology trainees and serves on the haematology scientific committee of the RCPA's annual meeting, Pathology Update. Dr Harvey is a member of the Haematology Society of Australia and New Zealand, the Australian Leukaemia & Lymphoma Group, the Australian Society of Thrombosis and Haemostasis and the Australian Medical Association.

Associate Professor Lyndal Anderson is a medical graduate of the University of Tasmania and commenced Pathology training in England in 2000. In Australia she trained at St Vincent’s Hospital Sydney and the Royal Prince Alfred Hospital before completing her Fellowship from the Royal College of Pathologists of Australasia in 2005.  She completed a Master of Philosophy in Gynaecological Pathology with The University of Sydney in 2011 and a Masters of Health Management with The University of New South Wales in 2012.  Her primary interests include Gynaecological Pathology and Cytopathology.   She is a Senior Staff Specialist at Royal Prince Alfred Hospital, an Associate Professor at Western Sydney University and an Associate Professor at The University of Sydney.  She is a member of the Research Advisory Committee for ANZGOG and a member of the Translational Research at ANZGOG committee.  She is a past President of the Australian Society of Cytology.

Dr Ian Clark is the Chief Executive Officer and Medical Director of Capital Pathology in Canberra. Ian graduated with first class honours from Sydney University in 1984 and trained in pathology at the Royal North Shore Hospital of Sydney. He was admitted to Fellowship in 1991, after which he joined the Douglass Laboratories practice in Sydney as a full-time specialist Anatomical Pathologist. He moved to Capital Pathology, in 1998 as Director of Histopathology and Medical Director, and became CEO in 2007. He is a Senior Clinical Lecturer at the ANU Medical School. Ian was President of the Australian Association of Pathology Practices (2007- 2009). He has been a member (and sometimes chair) of PSTC (2003-2011), chaired the Anatomical Pathology subcommittee of PSTC, and was a member of PCC (2006-2009). He was President of the Canberra Medical Society (2004-2006) and has been the ACT AMA craft representative for pathology and Honorary Secretary of the RCPA since 2011.

Andrew Clouston graduated in medicine from the University of Queensland and trained in anatomical pathology at the Princess Alexandra Hospital, developing a special interest in gastrointestinal and liver pathology. Since being awarded a PhD for studies into liver allograft immunopathology his research, funded by grants from the NHMRC, NIH and other funding bodies, has included studies on liver fibrosis, fatty liver disease, liver allograft rejection and gastrointestinal cancer.

He is currently the managing partner of Envoi Specialist Pathologists, a private practice in Brisbane specialising in gastrointestinal pathology that also has a strong emphasis on teaching and internationally competitive research. In addition, he is a visiting senior specialist to the Royal Brisbane and Women’s Hospital, Professor of Molecular and Cellular Pathology at the University of Queensland and Clinical Fellow at the Queensland Institute of Medical Research. He has served on a range of national and international committees including the International Consensus Panel for Liver Allograft Pathology, the International Collaboration on Cancer Reporting (ICCR) authoring committee (liver cancer), the National Bowel Cancer Screening Programme, and Australian Cancer Network/NHMRC committees for surveillance protocols in a range of gastrointestinal disorders. He is a frequent presenter at national and international conferences and in 2017 was selected as the RCPA Visiting Lecturer to Overseas.

Jane Dahlstrom is a medical graduate of Sydney University. After completing her PhD at the John Curtin School of Medical Research at the Australian National University (ANU) she entered speciality training in Anatomical Pathology. She is a Fellow of the Royal College of Pathologists of Australasia (RCPA) in Anatomical Pathology and in Oral Pathology and is a founding Fellow of the Faculty of Science of RCPA. Jane was admitted as a Senior Fellow of the Higher Education Academy (SFHEA) in 2014.

Jane has held a number of honorary positions within RCPA since 1999 including Chair of the Board of Education and Chair of the Cancer Services Advisory Committee. She is an examiner for RCPA in Anatomical Pathology and Oral Pathology. Since 2004 Jane have been involved in the Australian Medical Council (AMC) accreditation teams assessing medical schools and medical colleges. Jane is passionate about assisting pathologists from underserved regions of the world. Being current president of the International Paediatric Pathology Association (IPPA), chair of the Education Committee of International Academy of Pathology (IAP) and Vice President Asia-Pacific of IAP has enabled her to help promote collaborative educational activities of pathologists within these regions.

Jane is currently Sub Dean of Canberra Hospital Campus at the Australian National University Medical School, Professor of Anatomical Pathology and a Senior Staff Specialist at ACT Pathology, The Canberra Hospital.

Mr Will Daymond is a general commercial lawyer with extensive experience in in-house legal and private practice, partnering with stakeholders across the Asia Pacific region and the UK. Will advises on all aspects of law including sales, marketing, regulatory compliance, privacy, mergers & acquisition, employment, insurance, construction and litigation and has experience within the food & beverage, healthcare, automotive, telecommunications, media and finance industries. Will is currently Head of Legal and Compliance (ANZ) at Galderma. Prior to Galderma, Will was Group Legal Counsel Asia Pacific at Associated British Foods, responsible for 4 business units in Australia and New Zealand and was also jointly responsible for all IP and IT matters in the Asia Pacific Region. Will was previously an IP and IT lawyer at Corrs Chambers Westgarth, focusing on both litigious and transactional matters. In 2020, Will was awarded “In-House Lawyer of the Year” at the Australian Law Awards.

Dr Michael Dray is the President of the Royal College of Pathologists of Australasia. He completed much of his training in anatomical pathology in Sydney, NSW, before returning to New Zealand, where he worked as consultant pathologist at Middlemore Hospital for 6 years.

Middlemore Hospital, in Auckland, New Zealand is the site of the NZ Bone and Soft Tissue Tumour Registry and as such he spent a lot of time developing his interest in musculoskeletal pathology.

He has recently moved an hour and a half south to Waikato Hospital, in the city of Hamilton.

Dr Que Lam is a Monash University graduate who trained in Chemical Pathology at the Alfred Hospital and Dorevitch Pathology. She was admitted to Fellowship in 2006 and has since worked in private and public pathology laboratories in Victoria. She is currently staff specialist at St Vincent's Pathology in Melbourne and an Adjunct Fellow at the Centre for Health Systems and Safety Research, Australian Institute of Health Innovation at Macquarie University NSW.

Dr Lam is involved in various RCPA committees, has represented the College externally with RCPA-AQAP, NPAAC and is a NATA assessor.

Dr Robert Norton is the Director of Microbiology and Pathology at Townsville University Hospital.  He is Associate Professor, Faculty of Medicine, University of Queensland, and a past Chief Examiner in Microbiology of the RCPA

In his current capacity as Director of Microbiology at Townsville University Hospital, he has collaborated with researchers locally and nationally on projects relating to melioidosis, rheumatic fever, invasive group A streptococcal disease and Q-fever.